Insiders Eledon Pharmaceuticals, Inc.

Equities

ELDN

US28617K1016

Real-time Estimate Cboe BZX Other stock markets 01:28:12 11/05/2024 am IST			5-day change	1st Jan Change
2.275 ^USD	-5.21%		-6.22%	+25.56%

07/05	Eledon Pharmaceuticals, Inc. Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection	CI
06/05	Eledon Pharmaceuticals, Inc. announced that it expects to receive $49.99901 million in funding	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eledon Pharmaceuticals Names Eliezer Katz Chief Medical Officer	23/23/23	MT
Eledon Pharmaceuticals, Inc. Appoints of Eliezer Katz as Chief Medical Officer	23/23/23	CI
Eledon Pharmaceuticals Appoints Allan Douglas Kirk to Board of Directors	02/23/02	CI
Eledon Pharmaceuticals, Inc. Appoints James Robinson to Its Board of Directors, Effective October 1, 2023	12/23/12	CI
Eledon Pharmaceuticals, Inc. Announces Gary A. Lyons Not to Stand for Re-Election as Director	01/23/01	CI
Eledon Pharmaceuticals, Inc. Announces Executive Changes	02/21/02	CI
Eledon Pharmaceuticals Appoints Jan Hillson to Its Board of Directors	02/21/02	CI
Eledon Pharmaceuticals, Inc Announces Executive Appointments	20/21/20	CI
Eledon Pharmaceuticals, Inc. Announces Appointments Jeff Bornstein as Chief Medical Officer, Effective April 5, 2021	15/21/15	CI
Eledon Pharmaceuticals, Inc. Announces Appointments of Paul Little as Chief Financial Officer	15/21/15	CI
Novus Therapeutics, Inc. has Changed its Name to Eledon Pharmaceuticals, Inc	04/21/04	CI
Novus Therapeutics, Inc. Appoints June Lee to the Board of Directors	09/20/09	CI
Novus Therapeutics, Inc. Announces Management Changes	16/20/16	CI
Novus Therapeutics, Inc. Announces Executive Changes	16/20/16	CI
Novus Therapeutics, Inc. Announces Resignation of Gregory Flesher as Chief Executive Officer	05/20/05	CI
Novus Therapeutics, Inc. Appoints Jon Kuwahara as Interim Principal Executive Officer	05/20/05	CI
Novus Therapeutics, Inc. Announces Resignation of Cheryl Cohen as Director	18/20/18	CI
Novus Therapeutics, Inc. Announces Formation of Scientific Advisory Board	04/18/04	CI
Novus Therapeutics, Inc. Ratifies the Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2018	15/18/15	CI
Novus Therapeutics Announces Management Changes	07/17/07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Eledon Pharmaceuticals, Inc.

Equities

ELDN

US28617K1016

Insiders

Filters